Deutsche Bank AG set a €84.00 ($98.82) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Tuesday. The firm currently has a neutral rating on the stock.
Other equities research analysts have also recently issued research reports about the stock. Nord/LB set a €93.00 ($109.41) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, May 4th. J P Morgan Chase & Co set a €104.50 ($122.94) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, May 4th. Berenberg Bank set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, May 3rd. Goldman Sachs Group, Inc. (The) set a €100.00 ($117.65) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, May 3rd. Finally, Morgan Stanley set a €90.00 ($105.88) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Thursday, April 27th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Fresenius Medical Care AG & Co. KGaA presently has an average rating of Hold and an average price target of €88.21 ($103.78).
Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 76.464 on Tuesday. Fresenius Medical Care AG & Co. KGaA has a one year low of €70.82 and a one year high of €89.07. The company has a 50-day moving average of €82.91 and a 200-day moving average of €81.11. The stock has a market capitalization of €23.46 billion and a price-to-earnings ratio of 19.717.
COPYRIGHT VIOLATION NOTICE: “Deutsche Bank AG Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €84.00 Price Target” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/11/deutsche-bank-ag-analysts-give-fresenius-medical-care-ag-84-00-price-target.html.
Fresenius Medical Care AG & Co. KGaA Company Profile
Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
